Johnson & Johnson (JNJ) Revenue (2010 - 2025)

Johnson & Johnson has disclosed Revenue across 14 years of filings, most recently posting $94.2 billion for FY2025.

• Revenue for Q1 2026 came in at $24.1 billion, up 9.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.4 billion (up 7.87% YoY), and the FY2025 annual result was $94.2 billion, up 6.05% from the prior year.
• Revenue came in at $94.2 billion for FY2025 at Johnson & Johnson, up from $88.8 billion in the prior year.
• In the past five years, Revenue ranged from a high of $94.2 billion in FY2025 to a low of $78.7 billion in FY2022.
• The 5-year median for Revenue is $83.9 billion (2021), against an average of $84.9 billion.
• Across the five-year window, Revenue fell 4.65% in 2022 and gained 6.46% in 2023, its largest moves.
• Johnson & Johnson's Revenue stood at $82.6 billion in 2021, then dropped by 4.65% to $78.7 billion in 2022, then increased by 8.15% to $85.2 billion in 2023, then rose by 4.3% to $88.8 billion in 2024, then rose by 6.05% to $94.2 billion in 2025.
• The last three Revenue figures came in at $94.2 billion (FY2025), $88.8 billion (FY2024), and $85.2 billion (FY2023), per Business Quant data.